Comparing Two Injection Sites of Local Anesthetic for Hand Surgery

NCT ID: NCT02112006

Last Updated: 2016-03-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-04-30

Study Completion Date

2016-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare two different injection sites for local anesthesia in patients having hand surgery. The hypothesis is that subjects receiving injections around the three nerves of the forearm will provide faster pain control and greater patient satisfaction than patients having one injection closer to the shoulder.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hand Injury Wrist Injury Finger Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

distal injection

0.5% bupivacaine injected in the forearm

Group Type EXPERIMENTAL

0.5% bupivacaine injected in the forearm

Intervention Type PROCEDURE

Median, Ulnar, and Radial nerve blocks performed in the forearm

proximal injection

20-30ml of 0.5% bupivacaine

Group Type ACTIVE_COMPARATOR

20-30ml of 0.5% bupivacaine.

Intervention Type PROCEDURE

supraclavicular, infraclavicular, or axillary nerve block using 20-30ml of 0.5% bupivacaine.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

0.5% bupivacaine injected in the forearm

Median, Ulnar, and Radial nerve blocks performed in the forearm

Intervention Type PROCEDURE

20-30ml of 0.5% bupivacaine.

supraclavicular, infraclavicular, or axillary nerve block using 20-30ml of 0.5% bupivacaine.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients ≥ 18 years of age undergoing unilateral hand, wrist, or finger surgery
* Ability to understand and provide informed consent
* American Society of Anesthesiologists (ASA) status I-III

Exclusion Criteria

* Patient refusal or inability to provide informed consent
* True allergy, not sensitivity, to any of the following substances: Local Anesthetics, Midazolam, Fentanyl, Hydromorphone, Propofol
* Pregnancy
* Severe hepatic impairment
* Evidence of infection at or near the proposed needle insertion site
* Any sensorimotor deficit of the ipsilateral upper extremity, whether acute or chronic, as determined by the PI and designee
* Pulmonary disease of any kind that is uncontrolled or severe in nature
* Chronic pain patients, defined as someone diagnosed with chronic pain or a chronic pain condition, under the care of a chronic pain physician, or taking oral/intravenous narcotics consistently for 30 days prior to surgery
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jose Soberon, MD

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jose Soberon, MD

Anesthesiologist

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jose Soberon, MD

Role: PRINCIPAL_INVESTIGATOR

Ochsner Health System

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ochsner Clinic Foundation

New Orleans, Louisiana, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Soberon Forearm

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Ropivacaine Concentration and Rebound Pain
NCT06950372 RECRUITING PHASE4